Position in PFE
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$7,502,846
-$1,190,160 QoQ
Shares Held
311,580
+0.6% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.61%
of 13F equity value
Holder Rank
#488
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PAYDEN & RYGEL holds $102,478,534 across 7 Drug Manufacturers - General names. PFE ranks #6 (7.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
200,960 | $25,823,360 | |
| 2 | ABBV |
AbbVie Inc.
|
73,250 | $18,432,630 | |
| 3 | LLY |
ELI LILLY & Co
|
14,670 | $17,595,639 | |
| 4 | JNJ |
Johnson & Johnson
|
64,900 | $16,482,653 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
126,560 | $15,989,590 | |
| 6 | PFE |
Pfizer Inc
This page
|
311,580 | $7,502,846 | |
| 7 | AMGN |
Amgen Inc
|
1,800 | $651,816 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,502,846 | 311,580 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $8,693,006 | 309,580 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $5,106,492 | 205,080 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $9,682 | 380 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $598,243 | 24,680 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $625,391 | 24,680 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $654,760 | 24,680 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $9,086,581 | 313,980 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $838,840 | 29,980 | Shares | Sole | 2024-10-07 | |
| 2024-03-31 | $7,503,045 | 270,380 | Shares | Sole | 2024-10-08 | |
| 2023-12-31 | $863,124 | 29,980 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $994,436 | 29,980 | Shares | Sole | 2024-10-07 | |
| 2023-06-30 | $208,342 | 5,680 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $10,211,016 | 250,270 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $25,312,047 | 493,990 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $37,348,722 | 853,490 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $43,657,936 | 832,690 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $36,549,102 | 705,990 | Shares | Sole | 2022-04-13 | |
| 2021-12-31 | $29,316,553 | 496,470 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $21,353,174 | 496,470 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $19,441,765 | 496,470 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $18,099,421 | 499,570 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $17,995,304 | 488,870 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $18,675,510 | 508,870 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $15,917,395 | 486,770 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $15,888,151 | 486,770 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||